Lv4
490 积分 2025-04-19 加入
Combined use of Omalizumab and dupilumab: safety and efficacy data from a large academic center
4小时前
已完结
Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitis
4小时前
待确认
The effects of house dust mite sublingual immunotherapy in patients with allergic rhinitis according to duration
1个月前
已完结
SQ sublingual immunotherapy tablets for children with allergic rhinitis: A review of phase three trials
1个月前
已完结
Efficacy of a 3-Year Course of sUblingual Immunotherapy for Mite-Induced Allergic Rhinitis with a 3-Year Follow-Up
1个月前
已完结
Efficacy of a 3-Year Course of sUblingual Immunotherapy for Mite-Induced Allergic Rhinitis with a 3-Year Follow-Up
1个月前
已关闭
Efficacy of a 3-Year Course of sUblingual Immunotherapy for Mite-Induced Allergic Rhinitis with a 3-Year Follow-Up
1个月前
已关闭
Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy
1个月前
已完结
皖公网安备34019202002308
